Pioglitazone And Glimepiride Tablet
Product Images NDC 66993-822

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone And Glimepiride (NDC 66993-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pioglitazone 01)

Chemical Structure (Pioglitazone 01)
Chemical structure of pioglitazone and glimepiride with hydrochloride (HCl) salt notation shown.*
FDA Label Image

Chemical Structure (Pioglitazone 02)

Chemical Structure (Pioglitazone 02)
Chemical structure of the active ingredients pioglitazone and glimepiride, shown as a combined molecular diagram with labeled atoms and bonds representing their chemical composition.*
FDA Label Image

Principal Display Panel (30/2 mg Tablet Bottle Label)

Principal Display Panel (30/2 mg Tablet Bottle Label)
Label for Pioglitazone 30 mg and Glimepiride 2 mg tablets by Prasco Laboratories. The bottle contains 30 oral tablets. The label includes storage instructions, manufacturer details, usage warnings, and a barcode.*
FDA Label Image

Principal Display Panel (30/4 mg Tablet Bottle Label)

Principal Display Panel (30/4 mg Tablet Bottle Label)
Label for Pioglitazone 30 mg and Glimepiride 4 mg Tablets by Prasco Laboratories. The package contains 30 tablets, prescription only. The label includes storage instructions, dealer information, and a barcode. It states the combination of 30 mg pioglitazone hydrochloride and 4 mg glimepiride per tablet and advises dispensing with a medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.